The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study
Author(s)
Type
Journal Article
Date Issued
2013-05-07
ISSN
1932-6203
Publisher
PUBLIC LIBRARY SCIENCE
Journal / Book Title
PLOS ONE
Volume
8
Issue
5
Copyright Statement
2013 Stebbing et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Sponsor
Cancer Research UK
National Institute for Health Research
Cancer Research UK
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319654700045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
C37/A12011
NIHR-RP-011-053
14549
Subjects
Science & Technology
Multidisciplinary Sciences
Science & Technology - Other Topics
MULTIDISCIPLINARY SCIENCES
ESTROGEN-RECEPTOR
RANDOMIZED-TRIAL
DISEASE PROGRESSION
1ST-LINE TREATMENT
SOLID TUMORS
DOUBLE-BLIND
CROSS-TALK
PHASE-II
PLACEBO
GEFITINIB
Adult
Aged
Breast Neoplasms
Gene Amplification
Humans
Middle Aged
Neoplastic Cells, Circulating
Quinazolines
Receptor, Epidermal Growth Factor
Receptor, ErbB-2
Receptor, erbB-2
MD Multidisciplinary
General Science & Technology
Publication Status
Published
Article Number
ARTN e62543